Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Colon Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Active Not RecruitingNCT04616183
What this trial is testing

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+28 more
M.D. Anderson Cancer Center 46
Early research (Phase 1)Study completedNCT00019773
What this trial is testing

Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer

Who this might be right for
Carcinoma of the AppendixColorectal CancerSmall Intestine Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Large-scale testing (Phase 3)UnknownNCT00002893
What this trial is testing

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council 900
Large-scale testing (Phase 3)Study completedNCT00003287
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 554
Testing effectiveness (Phase 2)UnknownNCT00072553
What this trial is testing

Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT00077259
What this trial is testing

Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00551421
What this trial is testing

Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00066846
What this trial is testing

Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00640081
What this trial is testing

Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Cheryl Pugh 169
Testing effectiveness (Phase 2)Study completedNCT00022477
What this trial is testing

BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago 24
Large-scale testing (Phase 3)Ended earlyNCT00070122
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 2,200
Testing effectiveness (Phase 2)Study completedNCT00016978
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT00084773
What this trial is testing

Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center 28
Not applicableEnded earlyNCT02050737
What this trial is testing

Plasma Biomarkers C-RAC, ICORG 12-27, V1

Who this might be right for
Colorectal Cancer
Cancer Trials Ireland 109
Testing effectiveness (Phase 2)Study completedNCT00030342
What this trial is testing

Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer

Who this might be right for
Colorectal CancerKidney Cancer
St. Luke's Medical Center 60
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Next Page